154
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Phase solubility behavior of hydrophilic polymer/cyclodextrin/lansoprazole ternary system studied at high polymer concentration and by response surface methodology

, , &
Pages 236-241 | Received 01 Aug 2010, Accepted 01 Oct 2010, Published online: 10 Nov 2010

References

  • Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 2007;59(7):645–666.
  • Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007;329(1–2):1–11.
  • Zheng Y, Haworth IS, Zuo Z, Chow MS, Chow AH. Physicochemical and structural characterization of quercetin-β-cyclodextrin complexes. J Pharm Sci 2005;94(5):1079–1089.
  • Loftsson T, Masson M, Sigurjónsdóttir JF. Enhanced complexation efficacy of cyclodextrins. In: Labandeira Torres JJ, Vila-Jato JL, editors. Proceedings of the 9th International Symposium on Cyclodextrins, Santiago de Compostela, Spain. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1998:257–260.
  • Patel AR, Vavia PR. Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation. J Incl Phenom Macro Chem 2006;56(1–2):247–251.
  • Loftsson T. Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of water-soluble polymers. Pharmazie 1998;53(11):733–740.
  • Van Stam J, De Feyter S, De Schryver FC, Evans CH. 2-Naphthol complexation by β-cyclodextrin: Influence of added short linear alcohols. J Phys Chem 1996;100(51):19959–19966.
  • Yang H, Bohne C. Effect of amino acid co-inclusion on the complexation of pyrene with β-cyclodextrin. J Phys Chem 1996;100(34):14533–14539.
  • Skiba M, Nemati F, Puisieux F, Duchêne D, Wouessidjewe D. Spontaneous formation of drug-containing amphiphilic β-cyclodextrin nanocapsules. Int J Pharm 1996;145(1–2):241–245.
  • Veiga MD, Ahsan F. Study of surfactants/β-cyclodextrin interactions over mequitazine dissolution. Drug Dev Ind Pharm 1997;23(7):721–725.
  • Jug M, Bećirević-Laćan M. Multicomponent complexes of piroxicam with cyclodextrins and hydroxypropyl methylcellulose. Drug Dev Ind Pharm 2004;30(10):1051–1060.
  • Ribeiro LSS, Ferreira DC, Veiga FJB. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with β-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. Eur J Pharm Sci 2003;20(3):253–266.
  • Ribeiro L, Loftsson T, Ferreira D, Veiga F. Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether β-cyclodextrin binary and ternary complexes. Chem Pharm Bull 2003;51(8):914–922.
  • Valero M, Pérez-Revuelta BI, Rodríguez LJ. Effect of PVP K-25 on the formation of the naproxen:β-ciclodextrin complex. Int J Pharm 2003;253(1–2):97–110.
  • Vélaz I, Sánchez M, Martin C, Martínez-Ohárriz MC, Zornoza A. Interactions of naproxen with vinylpyrrolidone and β-cyclodextrin: A fluorimetric study. Int J Pharm 1997;153(2):211–217.
  • Sigurðardóttir AM, Loftsson T. The effect of polyvinylpyrrolidone on cyclodextrin complexation of hydrocortisone and its diffusion through hairless mouse skin. Int J Pharm 1995;126(1–2):73–78.
  • Valero M, Carrillo C. Effect of binary and ternary polyethyleneglycol and/or β-cyclodextrin complexes on the photochemical and photosensitizing properties of Naproxen. J Photochem Photobiol B Biol 2004;74(2–3):151–160.
  • Lahiani-Skiba M, Barbot C, Bounoure F, Joudieh S, Skiba M. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems. Drug Dev Ind Pharm 2006;32(9):1043–1058.
  • Valero M, Carrillo C, Rodríguez LJ. Ternary naproxen:β-cyclodextrin:polyethylene glycol complex formation. Int J Pharm 2003;265(1–2):141–149.
  • Hirlekar RS, Sonawane SN, Kadam VJ. Studies on the effect of water-soluble polymers on drug-cyclodextrin complex solubility. AAPS PharmSciTech 2009;10(3):858–863.
  • Zhang X, Wu D, Lai J, Lu Y, Yin Z, Wu W. Piroxicam/2-hydroxypropyl-β-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique. J Pharm Sci 2009;98(2):665–675.
  • Zhang X, Sun N, Wu B, Lu Y, Guan T, Wu W. Physical characterization of lansoprazole/PVP solid dispersion prepared by fluid-bed coating technique. Powd Tech 2008;182(3):480–485.
  • DellaGreca M, Iesce MR, Previtera L, Rubino M, Temussi F, Brigante M. Degradation of lansoprazole and omeprazole in the aquatic environment. Chemosphere 2006;63(7):1087–1093.
  • Lindenstruth K, Müller BW. W/O/W multiple emulsions with diclofenac sodium. Eur J Pharm Biopharm 2004;58(3):6216–27.
  • Sun N, Wei X, Wu B, Chen J, Lu Y, Wu W. Enhanced dissolution of silymarin/polyvinylpyrrolidone solid dispersion pellets prepared by a one-step fluid-bed coating technique. Powd Tech 2008;182(1):72–80.
  • Higuchi T, Connors KA. Phase-solubility techniques. Adv Anal Chem Instrum 1965;4:117–212.
  • Acarturk F, Kislal O, Celebi N. The effect of some natural polymers on the solubility and dissolution characteristics of nifedipine. Int J Pharm 1992;85(1–3):1–6.
  • Loftsson T, Fridriksdottir F, Gudmundsdottir TK. The effect of water-soluble polymers on aqueous solubility of drugs. Int J Pharm 1996;127(2):293–296.
  • Asbahr AC, Franco L, Barison A, Silva CW, Ferraz HG, Rodrigues LN. Binary and ternary inclusion complexes of finasteride in HPβCD and polymers: Preparation and characterization. Bioorg Med Chem 2009;17(7):2718–2723.
  • Loftsson T, Hreinsdóttir D, Másson M. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm 2005;302(1–2):18–28.
  • Rekharsky MV, Inoue Y. Complexation thermodynamics of cyclodextrins. Chem Rev 1998;98(5):1875–1918.
  • Loftsson T, Frioriksdóttir H, Siguroardóttir AM, Stefánsson E. Drug-cyclodextrin-polymer ternary complexes. Eur J Pharm Sci 1996;4(Suppl. 1):S144.
  • Barillaro V, Dive G, Bertholet P, Evrard B, Delattre L, Frederich M, Ziémons E, Piel G. Theoretical and experimental investigations of organic acids/cyclodextrin complexes and their consequences upon the formation of miconazole/cyclodextrin/acid ternary inclusion complexes. Int J Pharm 2008;347(1–2):62–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.